Novel effect of the high risk-HPV E7 CKII phospho-acceptor site on polarity protein expression.

Autor: Dizanzo MP; Instituto de Biología Molecular Y Celular de Rosario-CONICET, Facultad de Ciencias Bioquímicas Y Farmacéuticas, Universidad Nacional de Rosario, Suipacha 590. 2000, Rosario, Argentina., Bugnon Valdano M; Instituto de Biología Molecular Y Celular de Rosario-CONICET, Facultad de Ciencias Bioquímicas Y Farmacéuticas, Universidad Nacional de Rosario, Suipacha 590. 2000, Rosario, Argentina., Basukala O; Tumour Virology Laboratory, International Centre for Genetic Engineering and Biotechnology, Trieste, Italy., Banks L; Tumour Virology Laboratory, International Centre for Genetic Engineering and Biotechnology, Trieste, Italy., Gardiol D; Instituto de Biología Molecular Y Celular de Rosario-CONICET, Facultad de Ciencias Bioquímicas Y Farmacéuticas, Universidad Nacional de Rosario, Suipacha 590. 2000, Rosario, Argentina. gardiol@ibr-conicet.gov.ar.
Jazyk: angličtina
Zdroj: BMC cancer [BMC Cancer] 2022 Sep 25; Vol. 22 (1), pp. 1015. Date of Electronic Publication: 2022 Sep 25.
DOI: 10.1186/s12885-022-10105-5
Abstrakt: Background: Oncogenic Human Papillomaviruses (HPVs) base their transforming potential on the action of both E6 and E7 viral oncoproteins, which perform cooperative or antagonistic actions and thus interfere with a variety of relevant cellular targets. Among them, the expression of some PDZ-containing polarity proteins, as DLG1 and hScrib, is altered during the HPV life cycle and the consequent malignant transformation. Together with the well-established interference of E6 with PDZ proteins, we have recently shown that E7 viral oncoprotein is also responsible for the changes in abundance and localization of DLG1 observed in HPV-associated lesions. Given that the mechanisms involved remained only partially understood, we here thoroughly analyse the contribution of a crucial E7 post-translational modification: its CKII-dependent phosphorylation. Moreover, we extended our studies to hScrib, in order to investigate possible conserved regulatory events among diverse PDZ targets of HPV.
Methods: We have acutely analysed the expression of DLG1 and hScrib in restrictive conditions for E7 phosphorylation by CKII in epithelial culture cells by western blot and confocal fluorescence microscopy. We made use of genome-edited HPV-positive cells, specific inhibitors of CKII activity and transient expression of the viral oncoproteins, including a mutant version of E7.
Results: We here demonstrate that the functional phosphorylation of E7 oncoprotein by the CKII cellular kinase, a key regulatory event for its activities, is also crucial to counteract the E6-mediated degradation of the PDZ-polarity protein DLG1 and to promote its subcellular redistribution. Moreover, we show that the CKII-dependent phosphorylation of E7 is able to control the expression of another PDZ target of HPV: hScrib. Remarkably, we found this is a shared feature among different oncogenic HPV types, suggesting a common path towards viral pathogenesis.
Conclusions: The present study sheds light into the mechanisms behind the misexpression of PDZ-polarity proteins during HPV infections. Our findings stress the relevance of the CKII-mediated regulation of E7 activities, providing novel insights into the joint action of HPV oncoproteins and further indicating a conserved and most likely crucial mechanism during the viral life cycle and the associated transformation.
(© 2022. The Author(s).)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje